An audit of fusion CT-PET in the management of colorectal liver metastases
- 30 June 2006
- journal article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 32 (5) , 564-567
- https://doi.org/10.1016/j.ejso.2006.02.003
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Five-Year Survival After Resection of Hepatic Metastases From Colorectal Cancer in Patients Screened by Positron Emission Tomography With F-18 Fluorodeoxyglucose (FDG-PET)Annals of Surgery, 2004
- Positron emission tomography versus positron emission tomography/computed tomography: from “unclear” to “new-clear” medicineMolecular Imaging & Biology, 2004
- FDG-PET for the pre-operative evaluation of colorectal liver metastasesEuropean Journal of Surgical Oncology, 2004
- Value of integrated PET/CT for lesion localisation in cancer patients: a comparative studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2004
- FGD-PET in the follow-up of recurrent colorectal cancer.Colorectal Disease, 2003
- Clinical Applications of FDG‐PET in OncologyActa Medica Austriaca, 2002
- Positron emission tomography for evaluation of colorectal carcinomaSeminars in Roentgenology, 2002
- Resection of liver metastases from colorectal cancer: the real impact of the surgical marginEuropean Journal of Surgical Oncology, 1998
- Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings.Radiology, 1998
- PET in oncology: Will it replace the other modalities?Seminars in Nuclear Medicine, 1997